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Under National Collegiate Athletic Association (NCAA) rules, all Division I and
II student-athletes are subject to year-round drug testing. In addition to these
NCAA-mandated tests, the NCAA encourages each member school to establish
its own drug testing policy. Drug testing has been studied frequently, often from
the legal, athlete motivation, or economic perspectives. Yet, on the collegiate
level, it is unclear the extent to which drug testing policies vary across institutions
and divisions. Therefore, the purpose of this study was to compare the drug testing
policies of high- and low-performing athletic programs to determine whether
student-athletes competing on successful teams in revenue-generating sports are
held to different standards than those participating on less successful athletic
teams. Drug testing policies were collected from “high-performing” Division I
and II athletic programs (i.e., those ranked in the top 25 in football, men’s
basketball, or women’s basketball between 2012–2017); these policies were
compared with those of “low-performing” athletic programs (i.e., those ranked
in the bottom 50 of the Directors’ Cup between 2012–2017). The results indicate
several contrasts between high- and low-performing athletic departments in how
they penalize athletes for positive drug penalties, particularly at the Division I
level.
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According to National Collegiate Athletic Association (NCAA) rules, all
Division I and II student-athletes are required to complete year-round drug testing
(NCAA Sport Science Institute, 2017). If a student-athlete tests positive for a
banned substance under a NCAA-mandated test, the student-athlete will lose
eligibility to compete. In addition to these NCAA-mandated tests, the NCAA
encourages its members to establish institutional drug testing policies. For these
policies, member institutions can set their own penalties, which may range from
mandatory drug education sessions to dismissal from the athletic team. Drug
testing has been studied frequently, often from the legal (Pohlman & Schawab,
2005), athlete motivation (Zenic, Stipic, & Sekulic, 2011), or economic (Bahrke,
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2015) perspectives. Yet, on the collegiate level, it is unclear the extent to which
drug testing policies vary across institutions and athletic divisions.
Given the lack of uniform regulations, drug testing policies and penalties can
vary across institutions and may reﬂect an athletic department’s consideration for
its student-athletes’ well-being (Whitehill, Binkley, Wright, & Dell-Pruett, 2009).
For example, policies with penalties that include counseling or drug education may
aid a student-athlete by offering treatment and guidance. Frequency of testing may
be another deterrent to future use (Baudouin & Szymanski, 2016). Other penalties,
like suspension or expulsion, may be more punitive. Balancing the desire to win
with the responsibility to support their student-athletes, in some instances, schools
may turn to policies that avoid suspension or expulsion to maintain athlete
eligibility (Whitehill et al., 2009).
There is a wide range of penalties enforced by NCAA institutions. For
instance, the drug testing policies of the 2015 NCAA Men’s Final Four basketball
teams provide an example of the inconsistencies (Pells, 2015). Duke University,
the University of Kentucky, and Michigan State University all required suspen-
sions of varying lengths for a drug test infraction. A positive test at Duke imposed a
1-year minimum suspension, Michigan State mandated a 30-day suspension, and
Kentucky required the student-athlete to miss 10% of his season. On the other
hand, the University of Wisconsin did not mandate a suspension after the ﬁrst
positive drug test.
One suspected reason for the difference in penalties for banned substances
across institutions is that perennially successful athletic programs may desire more
lenient policies in order to maintain the eligibility of elite student-athletes,
particularly among universities that reap the ﬁnancial beneﬁts associated with
success in revenue-generating sports such as football or men’s basketball. Based
on the possibility that university administrators may value success in revenue-
generating sports more than nonrevenue-generating sports, Cooper and Weight
(2011) surveyed athletic directors at Division I institutions and found that success
in football and men’s basketball was perceived to be key to the ﬁnancial stability of
their department. The authors argued that although there are very few athletic
programs that turn a ﬁnancial proﬁt, many athletic directors envision successful
football and basketball programs as vehicles for ﬁnancial prosperity. The results of
Cooper and Weight’s study suggest athletic administrators may value success in
revenue-generating sports more than nonrevenue-generating sports; as a result,
they may institute policies designed to maintain student-athlete eligibility.
While researchers have previously studied athlete drug testing in terms of
approaches to drug testing and penalties for drug test infractions, it is less clear
whether the NCAA’s lack of an association-wide policy mandating institution-
level drug testing has led to a wide variance in drug testing policies across college
athletics. In this study, we compare the drug testing policies of high- and low-
performing athletic programs to determine whether student-athletes competing on
successful teams in revenue-generating sports are held to different standards than
those participating on less successful athletic teams. Speciﬁcally, we examine the
relationship between (a) an athletic program’s performance in football and men’s
and women’s basketball and (b) the school’s drug testing policy. Additionally, we
compare the drug testing policies of high- and low-performing athletic programs
to identify the degree to which they differ based on penalties for infractions, the
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availability of second-chance opportunities, and the inclusion of educational
components. Such inquiry may guide administrators when designing effective
positive drug testing penalties on campus or recommending broader reforms to
NCAA bylaws. As discussed in the next section, previous studies of drug testing
policies have provided an important foundation to more expansive reviews of
NCAA and institutional practices.
Literature Review
Variance in Drug Testing Policies
Although the NCAA conducts its own drug test screening, institutional drug testing
policies are determined by the athletic department. Unsurprisingly, testing rates
and penalties for failed tests can vary from institution to institution. A 2011 report
from the Associated Press showed wide disparities in the drug testing policies and
procedures of 51 institutions included in their sample; while some polices were
very strict (e.g., calling for more frequent drug test administrations and student-
athlete suspensions), others did not enforce suspensions after the ﬁrst positive
drug test.
The lack of a consistent testing policy can be problematic, as differences in
drug testing enforcement across institutions can elicit negative reactions from
student-athletes, administrators, and fans, because some drug testing policies may
be viewed as overly punitive in comparison to others. The varying policies may
lead to seemingly unfair advantages for some institutions, as a banned substance
violation at one institution may require the offending student-athlete to sit out from
competition, while the same type of violation committed at a rival institution
may result in a less restrictive penalty. This perceived advantage has led some
administrators to argue for more consistent drug testing guidelines. For example,
Bob Copeland, former director of athletics at Waterloo University, argued,
“Bottom line is, you need a common standard so you have a level playing ﬁeld”
(Pells, 2015, para. 21). As advocates of a uniform drug testing code have
suggested, universities seeking a competitive advantage may adopt weak testing
policies to protect student-athlete eligibility (Terlep, 2016). Although this strategy
is permissible per NCAA bylaws, it may promote an environment in which ath-
letic success overshadows the actual goals of the NCAA drug testing program,
including deterrence and protecting “the health and safety of the student-athletes
competing” (NCAA Sport Science Institute, 2017, p. 6).
An institution’s athletic division (e.g., I vs. II) may similarly inﬂuence drug
testing policies on campus. While NCAA Divisions I and II share the governing
body’s overall mission of making athletics a part of the educational experience,
institutions in each division may differ in how they choose to fund their athletics
programs and in the national attention they command (NCAA, 2016). In 2009, the
NCAA Committee on Competitive Safeguards and Medical Aspects of Sports
compiled institutional drug testing policies and procedures information from 491
institutions. Their analysis revealed a wide variance in drug testing programs
across the NCAA membership, including Division I Football Bowl Subdivision,
Football Championship Subdivision, and without football; Division II; and Divi-
sion III institutions. Based on the NCAA report, only 16% of Division I member
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institutions suspended their student-athletes after the ﬁrst positive drug test,
whereas the suspension rates for ﬁrst-time offenders at Division II and III
institutions were 57% and 69%, respectively (NCAA, 2009). While the NCAA’s
report illustrated the degree to which suspension rates for failed drug tests differed
across divisions, it offered little explanation for these disparities. In addition to
suspension rates, the NCAA report also showed a wide range of penalties for
the student-athlete who violated an institution’s banned substance rules, including
discussion with the team’s athletic trainer, physician, or coach; mandatory drug
education programs; referral to drug counseling; intra-squad discipline; suspension
from the team; and dismissal from the team (NCAA, 2009).
With the multitude of penalties levied by each institution, further investigation
is required to determine the randomness or intentionality of these disparities. In
either case, institutions implementing drug testing penalties need a guide to ensure
that highly-competitive sport programs maintain ethical standards, student-athlete
safety, and a positive school reputation. Additionally, drug testing is designed to
maintain the integrity of sport. Although the topic of drug testing student-athletes
can be polarizing—particularly when it comes to issues of privacy and the banned
substance list (e.g., Kessler, 2016; Sailors, Teetzel, & Weaving, 2012)—punitive
measures might be considered constructive if the intent of these policies is to
prevent drug use or provide substance abuse treatment (Bahrke, 2015). The
rationale and severity of drug test infractions are examined further in the next
section.
Penalties for Infractions
Zero-tolerance policies. Researchers suggest that most drug testing programs in
education include a zero-tolerance policy toward the use of banned substances.
Schools use a variety of restrictive measures in their drug testing policies to deter
drug use, including out-of-school suspensions, in-school suspensions, and expul-
sion. Despite the punitive measures taken by institutions through drug testing
policies, there is a lack of empirical evidence to support the effectiveness of these
penalties, and student-athletes may require customized intervention techniques to
curb substance abuse (Agley, Walker, & Gassman, 2012).
Stamm, Frick, and Hollie (2016) studied the rationale for punitive measures in
drug testing policies. In particular, they investigated why institutional adminis-
trators chose to implement different policies, especially those associated with a
zero tolerance for infractions. Some schools add a counseling component to their
drug testing policy, but this measure is typically a secondary penalty to the harsher
zero-tolerance policy guidelines that cause students to be removed from the school.
According to Stamm et al., excluding students from school as a penalty for a
positive drug test can prevent the student from beneﬁting from school support. That
is, students can be negatively impacted when facing expulsion as they lose access
to the positive adult interaction, counseling, and accountability they would receive
in a school setting. One reason cited by the researchers for a drug policy is to keep a
positive school environment that ensures safety and equality for all students in the
school. This research suggests the intent for developing a drug policy should
surround the needs of the institution, and not be speciﬁc to the individual student.
There has been little research on alternatives to taking students out of school.
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Stamm et al. (2016) found that although most schools do not mandate a full
suspension from school for the ﬁrst positive drug testing offense, the length of
suspension from a ﬁrst positive drug testing offense nevertheless varied across
institutions.
Out-of-school suspension is not the only form of punishment for a positive
drug test, but research shows it is among the most common. For example, Waddell
(2012) investigated drug testing policies at high schools and found only one school
in his study imposed an in-school suspension for ﬁrst-time positive drug test
offenders. All other schools included in the study’s sample suspended or expelled
students for their ﬁrst positive drug test (Waddell, 2012). Waddell suggested
penalties for a second positive drug testing “capture what a school is ultimately
prepared to do in response to this behavior and that the ﬁrst, to the extent that is
less severe, is some measure of grace being afforded to ‘ﬁrst-time offenders’”
(Waddell, 2012, p. 4). Waddell indicated the importance of drug testing, but more
research is needed on best practices and penalties for positive drug tests.
Counseling and drug education. Although counseling was also noted as being a
part of most of the drug testing policies studied by Stamm et al. (2016), few policies
mandated counseling or gave speciﬁc guidelines for conducting the counseling at
the intercollegiate level. Administrators were quick to add the zero-tolerance
policy to their drug programs, but research has not shown how counseling should
be conducted when students test positive. Bahrke (2015) indicated more schools
are only recommending drug counseling for positive drug tests, but most mandate
at least a suspension. On the other hand, Stinchcomb (2008) reported that more
than 90% of interscholastic athletic departments utilize an intervention approach
that focuses on “redirecting student drug use” (p. 43) though counseling or
rehabilitation programs.
When it comes to existing drug education programs, much of the curriculum
focuses on steroid and performance enhancing drug (PED) use instead of recrea-
tional drugs. According to Thomas, Dunn, Swift, and Burns (2011), many student-
athletes are unaware of the side effects of controlled substances and rely on Internet
resources rather than peers (e.g., friends and coaches) for information. However,
even though more student-athletes chose to get their information about drugs
online, they also expressed belief they would beneﬁt from more information about
banned substances and would be most receptive from a presentation by a person
with whom they could relate. Additionally, although student-athletes suggested
additional education would help prevent and manage the use of banned substances,
Thomas and colleagues’ (2011) study also showed that athletes were more
concerned about the potential penalties that could result from a positive test
than the potential side effects of the drugs.
Athletic administrators must also consider the possibility that “one-size-ﬁts-
all” policies may not be the most effective approach to meeting all student-athletes’
needs. For instance, Crosset, Filo, and Berger (2011) found that when athletic
departments use more mainstream ethical reasoning in comparison to punitive
penalties, African American student-athletes found more success. The researchers
posited that as African American student-athletes entered an environment with
unwritten policies and social norms that differed from those of White student-
athletes, they beneﬁtted more by nonpunitive measures after ﬁrst-time drug
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offenses. Like Agley et al. (2012), Crosset et al. (2011) advocated for customized
drug testing penalties based on the circumstances of individual student-athletes
rather than the adoption of a single uniform policy for the entire institution.
Approaches to Drug Testing
Fairness of drug testing. Commonly assumed in the debate over policies and
penalties is that drug testing at the intercollegiate level is an appropriate method
to ensuring a level playing ﬁeld. However, some scholars, such as Mitten (2009),
have challenged this assumption, arguing that Olympic athletes such as Michael
Phelps, Usain Bolt, and Eero Mäntyranta are already genetically advantaged in
their designated sports without using PEDs. Characteristics such as height, red
blood cell count, and ﬂexibility give certain athletes a biological advantage. Mitten
called into question the so-called fairness of other athletes trying to compete with
athletes born with physical advantages. In addition to physical characteristics,
ﬁnancial support and location can also play a role in an athlete’s ability to train at
better facilities and learn from better coaches. In summary, Mitten challenged the
legitimacy of “an equal playing ﬁeld”; in the absence of such equity, he questioned
why governing bodies prevented athletes from using steroids to reach their full
potential. In response to Mitten’s provocative question, Boxill (2009) argued that
restricting the use of PEDs and other banned substances was necessary because
they were harmful to the student-athletes taking them, they were harmful to other
student-athletes who could be coerced to use them, and they threatened the
integrity and nature of sport. Per Boxill (2009), “the death of ethics is the sabotage
of excellence” (p. 6). In other words, sport is about fair play, and governing bodies
should ensure ethical competition.
From an athletic participant perspective on the fairness of drug testing, Wilson
and Potwarka (2015) studied how an athlete’s passion predicted attitudes toward
PEDs. The study showed athletes with more obsessive passion toward athletics had
more positive attitudes toward using PEDs. Conversely, athletes with higher
harmonious passion toward athletics had less permissible attitudes toward the
use of PEDs. The passion an athlete had toward athletics provided an indicator of
his or her view of drug use in sport.
Frequency of testing. Another common consideration when designing a drug
testing protocol relates to the number of test administrations. In a recent study by
Baudouin and Szymanski (2016), the researchers explored the degree to which
increased drug testing deterred doping among Olympic athletes. The results
indicated that in some sports, such as track and ﬁeld, more frequent drug tests
would be effective in deterring drug use; however, in other sports, such as cycling,
additional testing did not deter doping. In cases in which there was not a negative
relationship between testing frequency and doping, Baudouin and Szymanski
suggested further research to determine how to discourage doping behaviors in
sports where more frequent test administrations were ineffective.
In settings where testing frequency could be tied to a decrease in drug offenses,
school ofﬁcials may encounter other challenges that prevent them from simply
instituting additional tests. First, a policy that allows for multiple test adminis-
trations per student-athlete may create an environment in which individuals feel
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targeted and persuade others to evade drug testing. For instance, Diacin, Parks, and
Allison (2003) found some student-athletes felt they were tested more than others,
as one student-athlete interviewed in the study noted:
I know a couple athletes have been tested more than once. And it seems like,
“why are they getting tested more than once?” They’ve already passed. And
there are people that are getting away with a lot of the stuff and never get
tested. The “random” tests might not be random enough. (p. 5)
Secondly, with additional tests come additional costs (Baudouin & Szymanski,
2016). Some college athletics departments might see the need to test but be hesitant
to do so because of the added costs. These constraints are discussed further below.
Rationale and constraints for drug testing policies. Researchers have sug-
gested the need to consider the rationale administrators use when constructing their
drug testing policies. Underlying this rationale may be constraints that inﬂuence
(positively or negatively) the support administrators can provide to students who
test positive. Drug testing is expensive and when an administrator is setting the
annual budget, it might be difﬁcult to justify the spending on drug testing when
there are other academic needs of the school (Bahrke, 2015). Contrasting the
research by Bahrke, Nite (2012) indicated athletic department personnel ﬁnd it
hard to justify spending on student-athlete development while under the pressure to
produce winning programs. Nite (2012) conducted interviews with athletic
department staff at Division II institutions and found that although participants
believed it was part of their responsibility to foster the overall development of
student-athletes, the limited resources and pressure to produce winning programs
prevented institutions from spending money outside of areas such as better
facilities. Drug testing procedures and penalties can be expensive, especially
when considering additional drug tests and counseling. These expenses can
prevent institutions from using these penalties when a student-athlete tests positive,
despite the potential beneﬁt to the student-athlete’s overall wellbeing. Despite the
contrasting views of spending between Nite’s and Bahrke’s research, both
researchers found that administrators were consciously electing not to invest in
student-athlete development programs.
Research further shows only a small number of positive drug tests result from
the many drug tests conducted (Bahrke, 2015). Fudala and Fields (1994) re-
searched the reaction of nonfaculty, faculty, and students to drug testing programs
and found there was a feeling of at least some support or no reaction to school drug
testing, but there was no perception of strong opposition in the groups studied.
This research indicates that there is no strong opposition to drug testing, and future
research needs not only to analyze the need for a drug testing policy, but also the
content of the policies themselves. Drug testing can be punitive, intrusive, and
unreliable (Fudala & Fields, 1994). These constraints can cause some hesitance on
the part of administrators to implement harsh drug testing policies.
Fudala and Fields’s (1994) research suggested students were all equally likely
to undergo drug testing for probable cause. However, Yamaguchi, Johnson, and
O’Malley, (2003) found it was more likely for students suspected of using drugs to
be tested. These contradictions support the need for additional research into drug
testing policies and procedures on campuses. More research suggested student
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attitudes and perceptions of drug use were bigger deterrents than the drug testing
policy. As illustrated throughout the literature review, previous work has been
limited and produced largely inconsistent ﬁndings. With this lack of an empirical
foundation in mind, a primary goal in this study is to determine whether the
competitiveness of a high-performing intercollegiate athletic program could in-
ﬂuence the drug testing penalties imposed by an institution. Additional objectives
are highlighted below.
Research Questions
Given the wide disparities in institutional drug testing policies, this study could aid
member institutions when establishing or reforming their drug testing policies and
determining best practices. Additionally, drug testing policies with more trans-
parent justiﬁcations could help individual student-athletes understand why they are
being tested and help them to appreciate why drug testing is a necessary part of
sport. Previous studies have highlighted different approaches to drug testing,
penalties for positive drug testing, and variances in drug testing in college athletics.
However, these studies have not addressed the underlying reasons for the incon-
sistencies in drug testing policies. In this study, we expand upon the ﬁndings of
the Associated Press (2011) report by exploring the role of program competitive-
ness in drug testing policies. The study was guided by the following research
questions (RQs):
RQ1: What penalties for banned substance violations are most common
among institutions with high- or low-performing Division I athletic programs?
RQ2: To what extent do the drug testing policies of Division I institutions with
high-performing athletic programs differ from those of Division I institutions
with low-performing athletic programs?
RQ3: What penalties for banned substance violations are most common
among institutions with high- or low-performing Division II athletic
programs?
RQ4: To what extent do the drug testing policies of Division II institutions
with high-performing athletic programs differ from those of Division II
institutions with low-performing athletic programs?
RQ5: To what extent do the drug testing policies of institutions with high-
performing athletic programs differ between Division I and II members?
Method
To examine differences between high- and low-performing athletic programs, we
used public polling data as proxies for athletic success. As a means of classifying
high-performing athletic programs, we identiﬁed all Division I and II institutions
that appeared in the top 25 postseason rankings in at least one of three sports—
football, men’s basketball, and women’s basketball—in the past ﬁve seasons
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(i.e., for football: 2012, 2013, 2014, 2015, or 2016; for basketball: 2012–2013,
2013–2014, 2014–2015, 2015–2016, or 2016–2017). For Division I and II
football and Division I basketball rankings, we used the respective Associated
Press Top 25 polls; for Division II men’s basketball, we used the National
Association of Basketball Coaches (NABC) top 25 poll; and for Division II
women’s basketball, we used the Women’s Basketball Coaches Association
(WBCA) top 25 poll. These three sports were selected because they are among the
costliest college sports to sponsor and command the highest coaches’ salaries
(with ice hockey; NCAA, 2015).
Low-performing athletic programswere selected using Learﬁeld Directors’Cup
rankings. The Directors’ Cup rankings are calculated using a points-based system in
which athletic programs are rewarded for success in a predetermined number of
sports. The Directors’ Cup is considered “the crowning achievement in college
athletics” because it recognizes “institutions maintaining a broad-based program,
achieving success in many sports, both men’s and women’s” (Learﬁeld Directors’
Cup, 2017, paras. 1–2). We included any institution appearing in the bottom 50
end-of-season rankings in the past ﬁve academic seasons (i.e., 2012–2013, 2013–
2014, 2014–2015, 2015–2016, or 2016–2017). There were no cases in which an
institution appeared in both the high-performing and low-performing lists.
Next, we collected these institutions’ drug testing policies from their respec-
tive athletic department websites. In cases in which the policies were not publicly
accessible, we contacted athletic administrators directly to request details on their
policies. In sum, we collected data from 348 institutions (i.e., nDI-high = 80; nDI-low
= 107; nDII-high = 90; nDII-low = 71). Each drug testing policy was analyzed for the
type of penalty (or penalties) assessed after a ﬁrst, second, and third violation; these
penalties included more frequent test administrations, mandated drug education or
counseling meetings, suspension from the team, and dismissal from the team.
Descriptive statistics were calculated for each institutional category (i.e., Top
25 Football, Top 25 Men’s Basketball, Top 25 Women’s Basketball, and Bottom
50 Directors’ Cup across Division I and II). Additionally, to identify differences
between high- and low-performing athletic programs, we conducted a chi-squared
test, the results of which are reported in the next section.
Results
As expected, the Division I institutions included in the sample tended to increase
the severity of a penalty after each drug test violation. Table 1 illustrates the most
common penalties for drug test infractions among Division I institutions; addi-
tionally, the table indicates the penalties in which high-performing institutions
differed from low-performing institutions.
To address RQ1, we examined the most common penalties for drug infractions
among high- and low-performing Division I institutions. The most common
penalties for ﬁrst-time offenders were increased test administrations and counsel-
ing across all institutional categories. Suspensions were employed by less than half
of high-performing programs, but 65% of low-performing programs. No institution
had a policy that dismissed a student-athlete from the team for a ﬁrst-time offense.
After a second banned substance violation, a suspension from the team was the
JIS Vol. 11, No. 1, 2018
32 Elliott, Kellison, and Cianfrone
most common penalty among all institutions. A third violation by a student-athlete
would result in a dismissal from the team in more than 40% of high-performing
institutions and more than 60% of low-performing institutions.
RQ2 related to the differences between high- and low-performing Division I
institutions. The results of chi-squared testing indicated statistically signiﬁcant
differences in several areas. For ﬁrst-time offenses, nearly two-thirds of low-
performing teams suspended student-athletes for a ﬁrst-time offense, while far
fewer high-performing programs utilized suspension as a penalty (football: 39%,
p < .001; men’s basketball: 35%, p < .001; women’s basketball: 41%, p < .01).
Further contrasts were reported in penalties assessed after a third test violation.
Much of these differences can be attributed to the fact that low-performing
programs were more likely to utilize team dismissals (61%) than other penalties,
while all four types of penalties were more evenly distributed among high-
performing teams.
RQs 2 and 3 focused on Division II institutions. In response to RQ3, we
evaluated the drug testing policies of high- and low-performing athletic programs,
the results of which are provided in Table 2.
Table 1 Penalties for Drug Test Infractions Among NCAA Division I
Institutions, Top 25 Athletic Programs Versus Bottom 50 Directors’
Cup Programs, 2012–2017
Top 25
Football
(n= 52)
Top 25
M Basketball
(n= 43)
Top 25
W Basketball
(n= 42)
Bottom 50
Directors’ Cup
(n= 107)
First offense
Increased frequency 87% 81% 88% 83%
Counseling 87% 81% 83% 88%
Suspension 39%*** 35%*** 41%** 65%
Dismissal 0% 0% 0% 0%
Second offense
Increased frequency 73% 67% 76% 68%
Counseling 79% 77% 81% 82%
Suspension 90% 88% 88% 89%
Dismissal 0% 2% 2% 7%
Third offense
Increased frequency 29%* 23% 21% 14%
Counseling 39%* 37%* 41%** 20%
Suspension 44%* 49%* 45%* 28%
Dismissal 48% 47% 43%* 61%
Abbreviations: M =men’s; NCAA =National Collegiate Athletic Association; W =women’s.
Note. Asterisk(s) indicate statistically signiﬁcant difference between top athletic program group
(i.e., Top 25 Football, Top 25 Men’s Basketball, Top 25Women’s Basketball) and the baseline group
(i.e., Bottom 50 Directors’ Cup). Percentages rounded to the nearest whole number.
*p < .05; **p < .01; ***p < .001.
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When it comes to overall penalties for violations, a pattern for Division I
institutions emerged: As the number of offenses increased, so did the severity of
the penalty. One notable exception relates to the use of suspensions. Division II
institutions were far quicker to suspend student-athletes for banned substance
violations; in fact, institutions with high-performing men’s basketball (80%) or
women’s basketball programs (85%) were more likely to suspend student-athletes
after a ﬁrst-time offense than low-performing programs (72%), though these
differences were not statistically signiﬁcant. After a second offense, institutions
across all categories utilized additional test administrations, counseling, and
suspension regularly. However, there was a signiﬁcant drop in these penalties
for a third offense, as all institutions relied most on team dismissals.
RQ4 related to the differences in drug testing policies between high- and low-
performing programs in Division II. Unlike Division I, penalties were mostly
consistent among (a) institutions with high-performing football, men’s basketball,
or women’s basketball and (b) those with low-performing athletic programs. There
were two cases in which penalties signiﬁcantly differed between high-performing
and low-performing programs: increased frequency after a ﬁrst offense in men’s
Table 2 Penalties for Drug Test Infractions Among NCAADivision II
Institutions, Top 25 Athletic Programs Versus Bottom 50 Directors’
Cup Programs, 2012–2017
Top 25
Football
(n= 39)
Top 25
M Basketball
(n= 45)
Top 25
W Basketball
(n= 34)
Bottom 50
Directors’ Cup
(n= 71)
First offense
Increased frequency 74% 62%* 68% 82%
Counseling 80% 78% 77% 83%
Suspension 67% 80% 85% 72%
Dismissal 0% 2% 0% 1%
Second offense
Increased frequency 59% 51% 47% 49%
Counseling 69% 60% 56% 55%
Suspension 80% 76% 77% 65%
Dismissal 8%** 20% 18% 34%
Third offense
Increased frequency 8% 9% 0% 9%
Counseling 10% 11% 3% 10%
Suspension 10% 11% 18% 13%
Dismissal 59% 53% 50% 48%
Abbreviations: M =men’s; NCAA =National Collegiate Athletic Association; W =women’s.
Note. Asterisk(s) indicate statistically signiﬁcant difference between top athletic program group
(i.e., Top 25 Football, Top 25 Men’s Basketball, Top 25Women’s Basketball) and the baseline group
(i.e., Bottom 50 Directors’ Cup). Percentages rounded to the nearest whole number.
*p < .05; **p < .01.
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basketball (62% vs. 82%, p < .05) and dismissal after a second offense in football
(8% vs. 34%, p < .01).
Finally, RQ5 centered on general differences between Division I and II
institutions. As discussed above, while there were a number of differences between
high- and low-performing institutions at the Division I level, there were compara-
tively fewer differences among Division II institutions. In other words, the drug
testing policies of high-performing Division I athletic programs varied from
institutions with less competitive athletic programs, whereas the drug policies
of high- and low-performing institutions in Division II were relatively consistent.
Discussion
The purpose of this study was to examine the relationship between intercollegiate
institutions’ athletic success and their drug testing policies. Speciﬁcally, the study
compared the drug testing penalties of institutions based on the success of their
athletic teams. Among Division I universities, the results of this study indicate
that the drug testing policies of institutions with strong football, men’s basketball,
or women’s basketball teams differ substantially from peers with less successful
athletic programs. For example, after a ﬁrst failed drug test, high-performing
athletic programs tend to penalize student-athletes in ways that protect their
eligibility (i.e., by increasing the frequency of subsequent test administrations
or mandating drug or alcohol counseling rather than suspending or dismissing
them from the team), while low-performing institutions suspend student-athletes
at a much greater rate. Additionally, after a third violation, most low-performing
institutions require the student-athlete to be dismissed from the team; on the other
hand, high-performing institutions utilized other forms of punishment. Contrarily,
differences in drug testing policies among Division II institutions were much less
common.
Arguments supporting reforms to the NCAA’s drug testing protocols point
to the perceived unfairness of institution-based penalties, in which a football
powerhouse could dictate more lenient penalties for drug offenses in order to keep
their best players on the ﬁeld (e.g., McMurphy, 2013; Murschel, 2015; Trahan,
2015;Weinreb, 2015). If a uniform policy is desired (Barnhart, 2016), the results of
this study suggest administrators should primarily focus their efforts on Division I
institutions. Division I institutions across all categories relied heavily on increased
testing administrations or counseling for ﬁrst-time drug offenses. While Baudouin
and Szymanski (2016) found the threat of increased testing could be a strong
deterrent to drug use in sports, it is unclear if the intent of these policies is to deter
drug use, protect athlete eligibility, or something else.
Given the widespread lack of empirical investigation on this topic, it is
unsurprising that the results of this study contradict some aspects of the existing
literature. For example, while Stamm et al. (2016) found that a zero-tolerance
policy was common among high school drug testing policies, intercollegiate
institutions largely relied on “second chance” penalties for ﬁrst- and second-
time offenses (with some exceptions, namely among Division II institutions).
Additionally, the fact that many programs utilized additional testing administra-
tions counters Bahrke’s (2015) suggestion that the expense of drug testing might
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prevent administrators from implementing effective policies. Of course, it is
possible that athletic administrators view the cost of additional drug tests as a
worthwhile investment if it deters student-athletes from committing additional
violations.
As discussed previously, among Division II institutions, there were few
differences between high- and low-performing institutions in their reliance on
increased test administrations, mandated counseling sessions, or suspensions or
dismissals from the team. Conversely, at the Division I level, universities with
more successful athletic programs had policies with more lenient penalties for
suspension after each round of positive drug tests. It remains unclear whether
administrators are deliberate when designing drug testing policies, and future
research is necessary to determine whether a uniform policy enforced by the
NCAAwould improve student-athlete wellness, curb the use of banned substances,
and uphold the standards of fair play any better than the existing system.
The NCAA conducts year-round drug testing and student-athletes are subject
to suspension from competition for positive results. In addition to the NCAA
policy, the NCAA recommends member institutions have their own drug testing
policies. Member institutions are not required to meet any guidelines when
creating their institutional policy; however, they are required to follow their
own policy and are subject to sanctions for failure to do so. As ﬁnances, student-
athlete well-being, and the competitive spirit of sport can impact an institution’s
drug testing policy, it is paramount that university administrators develop a drug
testing policy that addresses the needs of their institution and student-athletes.
The results of this study represent an initial survey of current practices among
the NCAA’s most successful (and unsuccessful) athletic departments; additional
inquiry can arm athletic administrators with the knowledge to implement more
effective drug testing policies and procedures. In the concluding section, we
outline the limitations of the current study and provide several suggestions for
future research.
Limitations and Directions for Future Research
As an initial investigation of drug testing policies and the impact of program
competitiveness, four categories of penalties were assessed; however, we acknowl-
edge institutional differences exist in testing processes and within the categories.
The number of student-athletes tested from each member institution yearly may
differ. The frequency of testing, types of counseling, and duration of suspensions
could differ in severity. For example, this study did not take into account the length
of a suspension. Institution suspensions can range from less than one game to an
entire season; in this study both lengths were considered the same suspension.
Additionally, in some cases, an institution may have separate penalties
depending on whether a banned substance violation is related to PEDs or
recreational drugs. In the few cases in which an institution included in this study
had two distinct policies, we reported the penalties for violations associated with
recreational drug use. Should a larger number of institutions begin distinguishing
between PED and recreational drug violations, subsequent analyses may be
conducted to determine the degree to which these separate policies contribute
to institutional differences.
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A professional in the ﬁeld should also take into consideration the expenses
associated with maintaining a rigorous drug testing policy. For instance, of the four
types of penalties analyzed in this study, increased test administrations and
mandated counseling sessions are associated with additional costs. Drug testing
policies that require student-athletes to participate in mandatory drug education
and counseling sessions could be more expensive and out of reach for institutions
with limited funding for such programs (Grasgreen, 2012; Pilon, 2013). In this
study, we did not differentiate between policies in which the cost of drug treatment
is the responsibility of the student-athlete or the institution (e.g., Georgia State
University, 2017).
The results presented in this paper suggest that while some top-performing
institutions have less punitive penalties compared to their lower-performing
institution counterparts, in other top-performing institutions there is no evidence
of such differences. Division I and II top-performing institutions show some
consistency in terms of penalties for ﬁrst, second, and third positive drug offenses,
but further research can examine with greater precision the effectiveness of
penalties and the positive impact the penalties have for the institutions and
student-athletes. This line of inquiry can help institutions identify best practices
and help administrators make decisions when it comes to drug testing policies and
procedures on campus.
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